Professor Andrew Beggs discusses best practice in the use of next-generational sequencing within thyroid and non-small cell lung cancers.
This content is intended only for healthcare providers and was made possible by educational funding provided by Illumina, Inc., and Eli Lilly and Company
Episode 5: Next-generation sequencing | Medicine Matters: The Springer Medicine Podcast - Listen or read transcript on Metacast
